Clinical Trials Logo

Lung Cancer Screening clinical trials

View clinical trials related to Lung Cancer Screening.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05630950 Active, not recruiting - Clinical trials for Lung Cancer Screening

LDCT-SC-FI Low-dose CT Screening for Lung Cancer

Start date: November 18, 2022
Phase: N/A
Study type: Interventional

This is a randomized phase II trial investigating different smoking cessation methods in study subjects undergoing lung cancer screening with low-dose CT (LDCT). The study also evaluates feasibility and outcomes of LDCT screening and potential biomarkers and AI-based evaluation on CT-scans. The study subjects fulfilling I/E-criteria are randomized in 1:1 fashion to yearly LDCT for two rounds with standard smoking cessation (control) or same LDCT approach combined to mobile application based smoking cessation (intervention).

NCT ID: NCT04691297 Active, not recruiting - Smoking Cessation Clinical Trials

Digitally Enhanced Smoking Cessation for High Risk Smokers

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

This is a research study, is testing a program to improve lung health through smoking cessation and providing education around lung screening. In this research study involves Studying the Enhanced Smoking Cessation Approaches to Promote Empowerment (ESCAPE) program compared to usual care. The ESCAPE program was developed help women with HIV quit smoking. Women in the ESCAPE program quit smoking and stayed quit for longer (up to 3 months). For this study, investigators have added a lung screening to the ESCAPE program and want to test if this will improve lung health through increasing quit rates and lung screening. .

NCT ID: NCT03069924 Active, not recruiting - Smoking Cessation Clinical Trials

Gain-framed Messages and NRT for Lung Cancer Screening Patients

Start date: July 1, 2017
Phase: Phase 2
Study type: Interventional

This research is a randomized smoking cessation trial conducted within and specifically personalized for lung cancer screening patients presenting to a lung screening clinic. Novel tobacco treatments for this population are critically needed, given the growing population of lung screening patients, which will grow dramatically now that lung screening is an approved CMS benefit. In the proposed study, we will test a gain-framed messaging intervention specifically designed for lung screening patients (vs. unframed messaging), as well as evaluating NRT sampling (vs. no medication) at 2 study sites. Our project is designed to be translational (in that it can be transferable from our controlled efficacy study to other lung screening programs).

NCT ID: NCT02914899 Active, not recruiting - Clinical trials for Lung Cancer Screening

Informing the Adaptation of a CHW Model to Facilitate Lung Cancer Screening for the Chinese Community

Start date: August 2016
Phase: Early Phase 1
Study type: Interventional

The purpose of this study is to test if our Community Health Worker program can help at-risk NYC Chinese community members participate in shared decision making and lung cancer screening (if appropriate) and compare it to the help provided by written materials.